BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 16, 2019
View Archived Issues
Sanofi begins phase I study of SAR-442085 in relapsed or refractory multiple myeloma
Read More
New phase I study investigates V-941 with KRAS-mutant solid tumors
Read More
New yellow fever therapeutic targets identified
Read More
Blood regulatory T cells mirror those in breast tumors
Read More
Stem cells don't need glutamine
Read More
Results presented from phase II ZEBRA study of pembrolizumab, the largest study in SBA to date
Read More
Preliminary data presented for patients with CRC enrolled in the phase I GATTO study
Read More
TAS-118 plus oxaliplatin improves survival compared to S-1 plus cisplatin in patients with AGC
Read More
Advaxis presents new immune data from ongoing ADXS-NEO phase I study
Read More
Activity maintained for recombinant factor VIII modified to extend half-life: MG-1121
Read More
AVROBIO announces first kidney biopsy results and additional data for AVR-RD-01
Read More
FLVCR1 predicts poor outcome in esophageal squamous cell carcinoma
Read More
Inscopix and Biogen announce research collaboration targeting chronic pain
Read More
NSI-189 shows promise in murine models of Alzheimer's disease
Read More
New public-private partnership to support phase III trial of Janssen's mosaic-based HIV vaccine
Read More
Sosei and Genentech enter GPCR-focused research collaboration and license agreement
Read More
Arbutus reports preliminary phase Ia/Ib data on oral HBV capsid inhibitor AB-506
Read More
Synlogic reports topline data from phase I/IIa study of SYNB-1618 in patients with PKU
Read More
Chengdu Huajian Future Technology patents IDO1 inhibitors
Read More
NIAID grant supports development of Kineta's LHF-535 for hemorrhagic arenaviruses
Read More
Janssen Pharmaceutica identifies menin/MLL interaction inhibitors
Read More
IDO1 inhibitors presented by Shanghai De Novo Pharmatech
Read More
Alkermes plans to expand planned ALKS-3831 schizophrenia NDA to include bipolar I disorder
Read More
MedImmune describes KEAP1/NRF2 interaction inhibitors
Read More
3M Pharmaceuticals patents new vaccine adjuvants
Read More
SurgiMab initiates phase III trial of SGM-101 in patients undergoing surgery for colorectal cancer
Read More